HOME
ABOUT
PIPELINE
NEWS & EVENTS
- News Releases
- Events
PARTNERSHIPS
FCOI
CONTACT

Enterococcal and Streptococcal Resistance to PC190723 and Related Compounds: Molecular Insights from a FtsZ Mutational Analysis.

Post navigation

An FtsZ-Targeting Prodrug with Oral Antistaphylococcal Efficacy in Vivo.

TXA497 as a Topical Antibacterial Agent: Comparative Antistaphylococcal, Skin Deposition, and Skin Permeation Studies with Mupirocin.

Search for:

Copyright © 2014-2022
TAXIS Pharmaceuticals, Inc.

HOME
ABOUT
PIPELINE
NEWS
PARTNERSHIPS
FCOI
CONTACT
Research & Development